Three years of paediatric regulation in the European Union

European Journal of Clinical Pharmacology

Volumn 67, Issue 3, 2011, Pages 245-252

  Olski, Thorsten M ^a   Lampus, Simona F ^a   Gherarducci, Giulia ^a   Saint Raymond, Agnes ^a  

^a EUROPEAN MEDICINES AGENCY   (United Kingdom)

Author keywords

European Medicines Agency; Paediatric committee; Paediatric investigation plan; Paediatric regulation

Indexed keywords

ARTICLE; CHILD HEALTH CARE; DRUG FORMULATION; DRUG RESEARCH; EUROPEAN UNION; HEALTH CARE AVAILABILITY; LEGAL ASPECT; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

AGE FACTORS; CHILD; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; EUROPEAN UNION; HUMANS; LEGISLATION, DRUG; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES;

EID: 79954447502     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-011-0997-4     Document Type: Article

References (14)

1. TJ Moore SR Weiss S Kaplan CJ Blaisdell 2002 Reported adverse drug events in infants and children under 2 years of age Pediatrics 110 e53 10.1542/peds.110.5.e53 12415059
2. S Avenel A Bomkratz DG Janaud DC JC 2000 Incidence des prescriptions hors autorisation de mise sur le marché en réanimation néonatale Arch Pediatr 7 143 147 1:STN:280:DC%2BD3c7msFyrtw%3D%3D 10.1016/S0929-693X(00)88083-5 10701058 (Pubitemid 30091004)
3. E Kozer D Scolnik T Keays K Shi T Luk G Koren 2002 Large errors in the dosing of medicines for children N Engl J Med 346 1175 1176 10.1056/ NEJM200204113461518 11948284 (Pubitemid 34984615)
4. I Choonara MJ Rieder 2002 Drug toxicity and adverse drug reactions in children-a brief historical review Paed Perinatal Drug Ther 5 12 18 10.1185/146300902322125109 (Pubitemid 34966670)
5. EMK Geiling PR Cannon 1938 Pathologic effects of elixir of sulphanilamide (diethylene glycol) poisoning JAMA 111 919 926 1:CAS:528:DyaA1cXmtV2lsA%3D%3D
6. R Steinbrook 2002 Testing medications in children N Engl J Med 347 1462 1470 10.1056/NEJMhpr021646 12409558 (Pubitemid 35239728)
7. E Schirm H Tobi TW de Vries I Choonara D Jong-van LTW den Berg 2003 Lack of appropriate formulations of medicines for children in the community Acta Paediatr 92 1486 1489 1:STN:280:DC%2BD2c%2Fot1amtg%3D%3D 10.1111/j.1651-2227. 2003.tb00837.x 14971804 (Pubitemid 38114502)
8. GW ť Jong BH Stricker I Choonara JN van den Anker 2002 Lack of effect of the European guidance on clinical investigation of medicines in children Acta Paediatr 91 11 1233 1238 10.1080/080352502320777487 (Pubitemid 35347041)
9. EH Davies CM Ollivier A Saint Raymond 2010 Paediatric investigation plans for pain: painfully slow! Eur J Clin Pharmacol 66 11 1091 1097 10.1007/s00228-010-0886-2 20821198 Epub 2010 Sep 7
10. MS Schreiner 2003 Paediatric clinical trials: redressing the imbalance Nat Rev Drug Discov 2 949 961 1:CAS:528:DC%2BD3sXpvFCgtr4%3D 10.1038/nrd1253 14654794 (Pubitemid 37540577)
11. R Smyth AM Weindling 1999 Research in children: ethical and scientific aspects Lancet 354 S2 21
12. R Roberts W Rodriguez D Murphy, et al. 2003 Paediatric drug labelling: improving the safety and efficacy of paediatric therapies JAMA 7 905 911 10.1001/jama.290.7.905 (Pubitemid 37430462)
13. T Stephenson 2005 How children's responses to drugs differ from adults Br J Clin Pharmacol 59 670 673 10.1111/j.1365-2125.2005.02445.x 15948930 (Pubitemid 40835499)
14. H Bartels 1983 Drug therapy in childhood: what has been done and what has to be done? Pediatr Pharmacol 3 131 143 1:STN:280:DyaL2c3kslSqsg%3D%3D (Pubitemid 14102395)